Le Lézard
Classified in: Health
Subject: SVY

Insights into the Global Hemorrhoid Treatment Devices Market, 2019 - A $963.1 Million Opportunity by 2026


DUBLIN, April 25, 2019 /PRNewswire/ -- The "Global Hemorrhoid Treatment Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 to 2026" report has been added to ResearchAndMarkets.com's offering.

Research and Markets Logo

The global hemorrhoid treatment devices market was valued at US$ 616.2 Mn in 2017 and is expected to reach US$ 963.1 Mn by 2026, expanding at a CAGR of 4.9% from 2018 to 2026.

Some prominent factors contributing to the incidence of hemorrhoids are an increase in intra-abdominal pressure during pregnancy or due to obesity, improper dietary habits, constipation, and other lifestyle factors. Despite its low morbidity, hemorrhoids have a prominent impact on the quality of life. However, this can be managed with a wide range of topical products and surgical and non-surgical treatments.

Lifestyle and dietary changes are the prominent conservative treatments for hemorrhoids. Lifestyle modification including increasing the fluid intake, reducing fat consumption, exercise, weight loss, and regular exercise are the mainstay. For symptomatic relief, corticosteroids, local anesthetics, and anti-inflammatory agents are prescribed. Several of these drugs are also available over the counter and therefore has led to less reporting for medical assistance.

For cases of internal hemorrhoids, sclerotherapy, band ligation, and infrared coagulation are the most commonly performed office procedures; however, there is no consensus on whether which of such treatments is the optimal option. Furthermore, the goal of each of these procedures is reducing the vascularity and redundant tissue, while ensuring rectal wall fixation. Other surgical procedures for hemorrhoid treatment include hemorrhoidectomy, stapled hemorrhoidopexy, and Doppler-guided hemorrhoidal artery ligation.

Based on the device type, the global hemorrhoid treatment devices market is classified into band ligators, sclerotherapy injections, cryotherapy devices, infrared coagulators, laser probes, bipolar probes, and others. Of these, band ligators due to high procedure rate dominate the global market. On the other hand, hospitals observe the largest patient footfall for hemorrhoid treatment and therefore is the biggest usage area for hemorrhoid treatment devices.

In terms of renal demarcation, North America dominates the global hemorrhoid treatment devices market. Presence of developed healthcare sector, high awareness about the availability of advanced treatment options, better reimbursements and fast commercialization of novel products aid the dominance of North America market.

Asia Pacific is anticipated to register high CAGR during the forecast period. Improving awareness and reducing inhibitions are the key factors driving the Asia Pacific market. Growing disposable incomes, technological advancements and evolving healthcare infrastructure are some of the other drivers in the Asia Pacific.

Considering the competitive landscape, the global hemorrhoid treatment devices market is highly fragmented with several companies together capturing over 50% share of the global market.

Key Market Movements

Topics Covered

Chapter 1. Preface
1.1. Report Description
1.2. Research Scope
1.3. Research Methodology
1.4. Market Segmentation

Chapter 2. Executive Summary
2.1. Global Hemorrhoid Treatment Devices Market Portraiture
2.2. Global Hemorrhoid Treatment Devices Market, by Type, 2017 (US$ Mn)
2.3. Global Hemorrhoid Treatment Devices Market, by Usage Area, 2017 (US$ Mn)
2.4. Global Hemorrhoid Treatment Devices Market, by Geography, 2017 (US$ Mn)

Chapter 3. Global Hemorrhoid Treatment Devices Market: Dynamics and Future Outlook
3.1. Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Porter's Five Forces Analysis
3.6. Attractive Investment Proposition, by Geography, 2017
3.7. Competitive Analysis: Global Hemorrhoid Treatment Devices Market, by Key Players, 2017

Chapter 4. Global Hemorrhoid Treatment Devices Market, by Type, 2016 - 2026 (US$ Mn)
4.1. Overview
4.2. Band Ligators
4.3. Sclerotherapy Injections
4.4. Cryotherapy Devices
4.5. Infrared Coagulators
4.6. Laser Probes
4.7. Bipolar Probes
4.8. Others

Chapter 5. Global Hemorrhoid Treatment Devices Market, by Usage Area, 2016 - 2026 (US$ Mn)
5.1. Overview
5.2. Hospitals
5.3. Clinics
5.4. Ambulatory Surgery Centers

Chapter 6. Global Hemorrhoid Treatment Devices Market, by Geography, 2016 - 2026 (US$ Mn)
6.1. Overview
6.2. North America Hemorrhoid Treatment Devices Market, 2016 - 2026 (US$ Mn)
6.3. Europe Hemorrhoid Treatment Devices Market, 2016 - 2026 (US$ Mn)
6.4. Asia Pacific Hemorrhoid Treatment Devices Market, 2016 - 2026 (US$ Mn)
6.5. Latin America Hemorrhoid Treatment Devices Market, 2016 - 2026 (US$ Mn)
6.6. Middle East & Africa Hemorrhoid Treatment Devices Market, 2016 - 2026 (US$ Mn)

Chapter 7. Company Profiles
7.1. Cook Medical
7.2. Medtronic PLC
7.3. Privi Medical
7.4. Sklar Corporation (Sklar Surgical Instruments)
7.5. Integra LifeSciences Corporation
7.6. OBP Medical Corporation
7.7. A.M.I. GmbH
7.8. CONMED Corporation
7.9. Boston Scientific Corporation
7.10. Ethicon (Johnson & Johnson)

For more information about this report visit https://www.researchandmarkets.com/r/6koy2u

Media Contact:

Laura Wood, Senior Manager
[email protected]  

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets


These press releases may also interest you

at 10:05
Grant support from the Bill & Melinda Gates Foundation will extend Sibel Health's AI-enabled, and FDA-cleared ANNE® One monitoring solution to improve maternal health monitoring globallySibel Health partners with the University of Edinburgh and the...

at 10:03
According to recent findings in Statista, "the United States is experiencing a growing demand for eco-friendly and sustainable feminine hygiene products. [In fact], in the United States, the revenue generated in the Feminine Hygiene market is...

at 10:00
VPL Rx, the clinically-minded prescription shipping, tracking, and compliance platform, announces its expansion into the pharmaceutical supply chain, setting a new standard for streamlined...

at 10:00
Binder Animal Hospital is thrilled to announce the expansion of its service offerings with the introduction of same-day urgent care for pets, available from 8 am to 8 pm, Monday through Saturday, effective April 1st, 2024. This development aims to...

at 10:00
The Ontario Brain Institute (OBI) has opened the doors to its new Centre for Analytics with the launch of two transformative, data-driven projects....

at 10:00
Pillar Biosciences, Inc., the leader in Decision Medicinetm, which develops and distributes next-generation sequencing (NGS) tests to localize testing and reduce time to treatment initiation and testing costs, today announced that the U.S. Food and...



News published on and distributed by: